Most Employers’ Retiree Rx Coverage Will Continue After Medicare Part D – Survey
This article was originally published in The Pink Sheet Daily
Executive Summary
Kaiser Family Foundation/Hewitt survey finds 58% of large employers plan to accept the government subsidy to continue offering retiree drug benefits that are actuarially equivalent to Part D. Only 8% expect to discontinue retiree Rx coverage.
You may also be interested in...
Employer Drug Coverage Will Shift To Part D, Stakeholders Say
Companies will accept the government subsidy for retirees’ drug coverage initially, but will move former workers to the Medicare drug benefit in later years, executives from Kaiser Foundation Health Plans and the Employers Coalition on Medicare predict.
GSK's Nucala Is Significantly Overpriced, ICER Draft Report Finds
New biologic for severe asthma doesn't stack up well to standard of care on generally accepted levels of cost per quality-adjusted life year.
Deal Watch: Sanofi, Boehringer Swap Side Businesses
Busy week for AstraZeneca sees buyout of Acerta and acquisition of remaining Daliresp/Daxas worldwide rights from Takeda. Amgen and GSK undo their cancer drug alliances from 2009 and 2010, with all rights reverting to the big biotech.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: